BradyXplore Phase II: Bradykinesia Feature Extraction System

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Parkinson's Disease
Trial Locations (2)

44195

Cleveland Clinic, Cleveland

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

collaborator

The Cleveland Clinic

OTHER

lead

Great Lakes NeuroTechnologies Inc.

INDUSTRY

NCT02358876 - BradyXplore Phase II: Bradykinesia Feature Extraction System | Biotech Hunter | Biotech Hunter